Background Nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) are widely
prescribed and are associated with blood pressure (BP) elevation. The development of …

Background Non-steroidal anti-inflammatory (NSAID) medications are a common cause of
reported adverse drug side-effects. This study describes the prevalence of non-steroidal anti …

Background The withdrawal of rofecoxib has highlighted concerns regarding the safety of
cyclooxygenase-2 (COX-2) inhibitors. In some patients COX-2 inhibitors may be safer than …

Objective: To assess trends in the first two years of prescribing of COX‐2‐selective non‐
steroidal anti‐inflammatory drugs (C2SNs) by Australian general practitioners. Design …

An Erratum has been published for this article in Pharmacoepidemiology and Drug Safety
14 (9), 2005, 669. Background The cyclooxygenase‐2 (COX‐2) inhibitor rofecoxib was …

Abstract Introduction. Cyclo-oxygenase-2 inhibiting (COXIB) anti-inflammatories have been
the drug class prescribed for a large number of cases of musculoskeletal (MSK) disorders in …

This study was conducted to evaluate the use of non-steroidal anti-inflammatory drugs
(NSAIDs) by consumers who obtained these drugs from community pharmacies. Factors that …

Objective To identify socio-demographic characteristics of the first patients receiving a new
drug—rofecoxib. Outcome measurement Patients starting on rofecoxib or another non …

Background and objective: Prescribers in rural and remote locations perceive that there are
different influences on their prescribing compared with those experienced by urban …

Coax, COX and cola | The Medical Journal of Australia MJA Basic Search Advanced search
search Use the Advanced search for more specific terms. Title contains Body contains Date …